Cargando…
Rituximab maintenance therapy for patients with diffuse large B-cell lymphoma: A meta-analysis
PURPOSE: The addition of rituximab to standard chemotherapy has significantly improved survival in patients with lymphoma. Recently, maintenance therapy with rituximab has been shown to prevent relapse and provide survival benefits for patients with follicular or mantle cell lymphoma. However, the e...
Autores principales: | Zhou, Xuan, Ma, Tingting, Zhang, Yichan, Zhou, Na, Li, Juan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5371376/ https://www.ncbi.nlm.nih.gov/pubmed/28355276 http://dx.doi.org/10.1371/journal.pone.0174648 |
Ejemplares similares
-
Primary breast diffuse large B-cell lymphoma in the era of rituximab
por: Zhang, Na, et al.
Publicado: (2016) -
Clinical analysis and prognostic significance of hepatitis B virus infections for diffuse large B-cell lymphoma with or without rituximab therapy
por: XIE, WANZHUO, et al.
Publicado: (2013) -
Maintenance therapy for untreated diffuse large B-cell lymphoma: a systematic review and network meta-analysis
por: Yuan, Ting, et al.
Publicado: (2021) -
A case of irreversible bradycardia after rituximab therapy for diffuse large B-cell lymphoma
por: Ko Ko, Nway Le, et al.
Publicado: (2020) -
Efficacy of rituximab combined with CHOP for treating patients with diffuse large B-cell lymphoma
por: Hu, Xin, et al.
Publicado: (2017)